Choksi Laboratories Ltd. (BSE: 526546) is a Indore, Madhya Pradesh-based company in the Consulting Services industry. With a market capitalisation of ₹141 Cr, it ranks #2,969 by market cap among the 6,137 Indian listed companies on FinBizNet, and #11 of 30 in Consulting Services. At ₹207.75 (as of 25 Oct 2026), the share price is 8.3% below its 52-week high of ₹226.65 and 131.7% above its 52-week low of ₹89.65. The share price is up 24.8% over one year and up 84.2% over three months.
| Current Price | ₹207.75 |
|---|---|
| Market Cap | ₹141 Cr |
| BSE Code | 526546 |
| Sector | Industrials > Commercial and Professional Services > Professional Services |
| Sub-Industry | Research and Consulting Services > Consulting Services |
| P/E Ratio | 71.8 |
| Return on Equity | 7.99% |
| Return on Assets | 4.61% |
| 52-Week Range | ₹89.65 – ₹226.65 |
| 1-Year Price Change | +24.8% |
| 3-Month Price Change | +84.2% |
| Beta (1Y) | 0.24 |
| Headquarters | Indore, Madhya Pradesh |
| Website | www.choksilab.com |
Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. Its contract laboratory services include pharmaceutical, food and beverages, soil and water, chemical, and construction material analysis. The company’s instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory. It also offers environment management, laboratory set-up and management, waste water management, and air pollution monitoring services. In addition, the company provides clinical research services, such as bio-availability and bio-equivalence studies; and consultancy and allied services consisting of training, third-party inspection, and auditing. Further, it offers assaying and hallmarking services for gold and silver. The company serves the pharmaceuticals, consumer products,
1. Analysis and Testing-This segment provides contract testing and analytical services.
1. Analysis and Testing-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| L&T Technology Services Ltd (Ltts) | ₹39,407 Cr | 31.3 | 19.54% | ₹3,040 Cr | -6.8% |
| Central Mine Planning & Design Institute Ltd (CMPDI) | ₹14,611 Cr | 23 | 28.36% | ₹593 Cr | — |
| International Gemological Institute Limited | ₹14,119 Cr | 25.2 | 47.80% | ₹398 Cr | +11.6% |
| Latent View Analytics Limited | ₹5,032 Cr | 25.1 | 12.17% | ₹287 Cr | -49.1% |
| Emudhra Limited | ₹4,560 Cr | 41.5 | 13.26% | ₹191 Cr | -46.0% |
| Pacheli Industrial Finance Ltd | ₹1,787 Cr | 16,750 | 0.01% | ₹0 Cr | +5.8% |
| Qualitek Labs Limited | ₹644 Cr | 43.3 | — | — | +23.0% |
| Likhami Consulting Ltd | ₹307 Cr | 1,320.5 | 0.66% | — | +3.3% |
| Choksi Laboratories Ltd. | ₹141 Cr | 71.8 | 7.99% | — | +24.8% |
Listed by market capitalisation. Ratios are shown for context only.
Choksi Laboratories Ltd. is trading at ₹207.75, with a market capitalisation of ₹141 Cr.
Choksi Laboratories Ltd. operates in the Industrials > Commercial and Professional Services > Professional Services space (Research and Consulting Services > Consulting Services).
Choksi Laboratories Ltd. has a P/E of 71.8 and a return on equity of 7.99%.
Choksi Laboratories Ltd. is listed on the BSE under the scrip code 526546.
Choksi Laboratories Ltd.'s share price is up 24.8% over one year and up 84.2% over three months. Its 52-week range is ₹89.65 to ₹226.65.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.